IMMUNOSTIMULATORY ADJUVANTS MARKET ANALYSIS

Regional Analysis

Immunostimulatory Adjuvants Market – Regional Insights

Based on the region, the global immunostimulatory market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America immunostimulatory adjuvants market holds the dominant position in terms of revenue. Moreover, Presence of major market players in U.S. region and increasing federal support towards the growth of healthcare sector is propelling growth of the immunostimulatory adjuvant market. For instance, the Center for Diseases Control and Prevention (CDC) was allocated US$ 324,350,000 in the 2016, for the public health immunization and to increase vaccine coverage among adults, adolescents, and children. Asia Pacific is expected to gain significant market share in the global immunostimulatory adjuvants market, followed by Europe, owing to high prevalence of various chronic disease such as tuberculosis, measles, and rubella. For instance, according to the World Health Organization (WHO) around 2.79 million incidence cases of tuberculosis were registered in India in 2016.